Logo Image
Articles
Media
All VideosCase Based Roundtable SeriesEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsViewpoints
Publications
Digital EditionSupplements And Featured Publications
Conferences
Conference Listing
More
CME/CE
Resources
SponsoredZEISS Clinical CasesZeiss Cataract InsightsZeiss Cataract DigitalizationEnhancing the Patient JourneyEYLEA 8mg for nAMD and DME TreatmentBetween the Lines

Subscribe

  • Articles
  • Media
  • Publications
  • Conferences
  • CME/CE
  • Resources
  • Subscribe
  • AMD
  • Cataract & Refractive
  • Cornea
  • Gene Therapy
  • Glaucoma
  • Inflammation & Infection
  • Paediatrics
  • Retina
Spotlight -
ZEISS Clinical Cases|
Heidelberg Engineering: Enhancing the Patient Journey
Advertisement

Dr Antoine Roure

Advertisement

Articles by Dr Antoine Roure

Experiencing the PresbyLASIK procedure as both surgeon and patient

Experiencing the PresbyLASIK procedure as both surgeon and patient

ByDr Antoine Roure
January 31st 2022

Laser vision advancements have made safe, reliable and stable procedures a reality.

Advertisement

Latest Updated Articles

  • Experiencing the PresbyLASIK procedure as both surgeon and patient
    Experiencing the PresbyLASIK procedure as both surgeon and patient

    January 31st 2022



Advertisement
Advertisement

Trending on Ophthalmology Times Europe

1

DEX implant shows benefit across RVO subgroups in real-world retrospective study

2

Lumvoa gains US FDA approval for thyroid eye disease with class-first broad label

3

European Dry Eye Society Congress 2026: real-world evidence on Artelac Complete in dry eye disease

4

Q&A: Uveitis risk rises as immune checkpoint inhibitor use expands

5

Study examines accommodation after iris-fixated phakic IOL implantation

  • Advertise
  • About Us
  • Editorial Info
  • Editorial Board
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us